Chemoinformaics analysis of 5,6,7-TRIMETHOXY-2-PHENYLCHROMEN-4-ONE
| Molecular Weight | 312.321 | nRot | 4 |
| Heavy Atom Molecular Weight | 296.193 | nRig | 18 |
| Exact Molecular Weight | 312.1 | nRing | 3 |
| Solubility: LogS | -4.398 | nHRing | 1 |
| Solubility: LogP | 3.375 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 2 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 17 |
| nHA | 5 | APOL | 44.7387 |
| nHD | 0 | BPOL | 23.8633 |
| QED | 0.738 |
| Synth | 2.102 |
| Natural Product Likeliness | 0.848 |
| NR-PPAR-gamma | 0.513 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.999 |
| Pgp-sub | 0.001 |
| HIA | 0.005 |
| CACO-2 | -4.61 |
| MDCK | 0.0000262 |
| BBB | 0.121 |
| PPB | 0.848699 |
| VDSS | 0.769 |
| FU | 0.112583 |
| CYP1A2-inh | 0.835 |
| CYP1A2-sub | 0.97 |
| CYP2c19-inh | 0.923 |
| CYP2c19-sub | 0.637 |
| CYP2c9-inh | 0.818 |
| CYP2c9-sub | 0.908 |
| CYP2d6-inh | 0.055 |
| CYP2d6-sub | 0.89 |
| CYP3a4-inh | 0.652 |
| CYP3a4-sub | 0.563 |
| CL | 3.746 |
| T12 | 0.325 |
| hERG | 0.23 |
| Ames | 0.577 |
| ROA | 0.134 |
| SkinSen | 0.574 |
| Carcinogencity | 0.188 |
| EI | 0.426 |
| Respiratory | 0.186 |
| NR-Aromatase | 0.84 |
| Antiviral | Yes |
| Prediction | 0.786653 |